Rates of adrenal insufficiency using a monoclonal vs. polyclonal cortisol assay
- PMID: 34890170
- DOI: 10.1515/jpem-2021-0519
Rates of adrenal insufficiency using a monoclonal vs. polyclonal cortisol assay
Abstract
Objectives: The diagnosis of adrenal insufficiency relies on clear cut-offs and accurate measurement of cortisol levels. Newer monoclonal antibody assays may increase the rate of diagnosis of adrenal insufficiency if traditional cortisol cut-off levels <18 mcg/dL (500 nmol/L) are applied. We aimed to determine if the rate of diagnosis of adrenal insufficiency using a 1 mcg Cosyntropin stimulation test varied with the change in cortisol assay from a polyclonal to a monoclonal antibody assay.
Methods: Cortisol levels obtained during the 1 mcg Cosyntropin stimulation test performed in the last semester of 2016 using a polyclonal antibody cortisol assay were compared to tests performed using a monoclonal antibody cortisol assay during the first semester of 2017. Cosyntropin tests included cortisol values obtained at baseline, 20 min and 30 min after IV administration of 1 mcg Cosyntropin. Peak cortisol cut-off value <18 mcg/dL was used to diagnose adrenal insufficiency.
Results: Stimulated cortisol values after 1 mcg Cosyntropin using the monoclonal assay in 2017 (n=38) were significantly lower (33%) compared to those obtained with the polyclonal assay in 2016 (n=27) (p-value <0.001). The number of passing tests with a peak cortisol value >18 mcg/dL fell from 74% in 2016 (20 out of 27 tests) to 29% in 2017 (11 out of 38 tests).
Conclusions: The change in cortisol assay substantially increased the number of patients diagnosed with adrenal insufficiency after 1 mcg Cosyntropin stimulation testing. Standardization of cortisol assays and diagnostic criteria is critical for the accurate diagnosis of adrenal insufficiency.
Keywords: adrenal insufficiency; cortisol; cut-off levels; steroid analysis.
© 2021 Walter de Gruyter GmbH, Berlin/Boston.
References
-
- Johannsson, G, Falorni, A, Skrtic, S, Lennernäs, H, Quinkler, M, Monson, JP, et al.. Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy. Clin Endocrinol 2015;82:2–11. https://doi.org/10.1111/cen.12603.
-
- Bowden, SA, Henry, R. Pediatric adrenal insufficiency: diagnosis, management, and new therapies. Int J Pediatr 2018;2018. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236909/ [Cited 31 Jan 2020].
-
- Bornstein, SR, Allolio, B, Arlt, W, Barthel, A, Don-Wauchope, A, Hammer, GD, et al.. Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2016;101:364–89. https://doi.org/10.1210/jc.2015-1710.
-
- Abdu, TA, Elhadd, TA, Neary, R, Clayton, RN. Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease. J Clin Endocrinol Metab 1999;84:838–43. https://doi.org/10.1210/jcem.84.3.5535.
-
- Zarković, M, Cirić, J, Stojanović, M, Penezić, Z, Trbojević, B, Drezgić, M, et al.. Optimizing the diagnostic criteria for standard (250-microg) and low dose (1-microg) adrenocorticotropin tests in the assessment of adrenal function. J Clin Endocrinol Metab 1999;84:3170–3. https://doi.org/10.1210/jc.84.9.3170.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources